United States: Health Care Congressional Outlook For The June Work Period

The next six weeks are shaping up to be the final work period before the summer recess, with both chambers scheduled to leave DC by July 15th for party conventions followed by the August recess. The National Defense Authorization Act (NDAA), appropriations, and Puerto Rico will take up the lion's share of time we have left remaining on the schedule. In the health care space, there are still a number of issues that both chambers will have to address or leave in the balance for when both chambers return to session September 6th.

After July 15, there is about a month and change of legislative days left on the calendar in 2016, with most of that time coming in September. This makes prioritizing the issues with the best chance of making it to the President's desk that much more important. Let's start with what is most likely to happen this work period.

Opioid Legislation

There are a few questions that will have to be answered this month. First is whether a conference committee can actually resolve the differences between the 18 passed bills from the House and the Senate-passed Comprehensive Addiction and Recovery Act. The next is whether Congress will appropriate enough money to address the problem. The latest numbers leave Congressional Democrats and the Administration about $500 million apart, with Republicans insisting that any funding be offset. Action is certainly possible during this work period but policy and funding challenges remain.

This is an issue that has received consistent headline news, which could help to drive congressional action.

Mental Health

While there has been some speculation that the Senators may try to incorporate mental health legislation into the opioid conference committee, there are those who also feel that method would only slow down the process of finalizing an opioid package.

In the House, the full Energy & Commerce committee is expected to mark up the H.R. 2646, the bill introduced by Rep. Tim Murphy (R-PA) which was advanced by the health subcommittee six months ago. The bill, which expands mental health programs and training, was over patient privacy rights, outpatient treatment programs, and cost. As of last week, aides on both sides of the aisle have been meeting to hash out differences in the hopes of bringing more Democrats into the fold.

After an attempt at passing mental health reform by unanimous consent in the Senate failed, the Senate will have to go through the process via floor time. With appropriations bills and other non-health related priorities stacking up, how much floor time they can devote to mental health is a valid question. If the House passes something in short order, it may breathe life into the potential for a conference committee. This could set in motion a conference to be worked out over the summer recess, assuming both chambers can pass legislation.

Zika Funding

Democrats and Republicans in both chambers attempted to negotiate a deal on Zika funding before the Memorial Day recess, but settling on a figure that satisfies both parties is proving elusive. While President Obama has requested $1.9 billion for a national and global response, the Senate passed a $1.1 billion dollar package, and the House plan calls for $622 million but faces a veto threat from the White House.

Minority Leader Harry Reid (D-NV) is threatening to force a vote on full funding for Zika, but that is likely more an issue for the House side should they hold firm at their $622 million dollar package. In the meantime, the House took the procedural step to initiate a conference committee with the Senate on combining Zika funding with other appropriations bills, and work on that is expected to resume this week.

21st Century Cures

The Senate's version of the 21st Century Cures Act has been making gradual progress for much of 2016 and this work period will likely be the last opportunity for meaningful progress before the summer recess. Whether or not the Senate can consider this package on the floor will depend on how quickly the Senate can wrap up its work on NDAA and other appropriations bills, not to mention the issues already outlined in this article.

Last month, FDA Commissioner Robert Califf warned that the current Cures package could pose a significant risk to patients if the legislation fails to preserve safety and effectiveness standards. That will likely be something for the conference committee to consider, as securing passage in the Senate will be a heavy lift for HELP Committee Chairman Lamar Alexander (R-TN), who has been heading the Senate's Cures effort from the beginning.

Once the Senate passes its version, they will still have to go to conference with the House 21st Century Cures Act. The sooner they can get that done, the easier it will be to finalize a package this Congress.

Affordable Care Act

Last month, Representative Pete Sessions (TX-32) and Senator Bill Cassidy (R-LA) unveiled legislation which they think brings a practical ACA alternative to the table. The legislation would create a tax benefit of up to $2,500 per adult and $1,500 per dependent child which could then be transferred to a Roth health savings account to be used to purchase health insurance or pay for health care services. The legislation would also repeal the individual and employer mandate.

Republican leaders are expected to unveil a health plan sometime this month that would both repeal and replace the ACA. It is expected to be released as close to the July convention as possible, and will primarily consist of principles rather than concrete policy proposals, presumably to give members breathing room as they campaign at home. Still, Republicans have promised an alternative for a long time and we may finally see the foundation for such a plan.

The Republican plan is expected to include a proposal which caps the exclusion on employer health insurance. The GOP has already begun reaching out to stakeholders on the proposal, hoping to ease any concerns prior to the launch of the paper. It remains to be seen whether this new package will significantly alter the health reform debate.

Hearings Next Week

The Energy & Commerce Health Subcommittee will hold a hearing Friday, June 10, 2016, titled "Advancing Patient Solutions for Lower Costs and Better Care." This hearing will review five bills, including the Aligning Children's Dental Coverage Act, as well as legislation designed to address special enrollment periods, among others. For more information on this hearing, click here.

The Energy & Commerce Health Subcommittee will hold a markup on Tuesday, June 7, 2016, on bills H.R. 3299 and H.R. 921. Those two bills are H.R. 3299, the Strengthening Public Health Emergency Response Act of 2015, and H.R. 921, the Sports Medicine Licensure Clarity Act of 2015. For more information on this hearing, click here.

The House Ways & Means Committee will hold a hearing Wednesday, June 8, 2016, titled, "Hearing on Legislation to Improve and Sustain the Medicare Program." For more information on this hearing, click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Rodney L. Whitlock
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.